Advertisement
Home »

Q&A: Self-Administered Tool Significantly Improves Cognitive Impairment Detection

Aug 25, 2024

REFERENCES & ADDITIONAL READING

Scharre DW, et al. Self-administered Gerocognitive Examination (SAGE) Aids Early Detection of Cognitive Impairment at Primary Care Provider Visits. Front Med (Lausanne). 2024;11:1353104. Published 2024 Jun 13. doi:10.3389/fmed.2024.1353104

ABOUT THE EXPERTS

  • Douglas W. Scharre, MD

    Photo Credit: The Ohio State Wexner Medical Center

    Clinical Professor of Neurology
    The Ohio State Wexner Medical Center
    The Ohio State University

     

    Dr. Scharre indicated to Physician’s Weekly that he is a consultant to BrainTest and Otsuka, has been on the advisory board and speakers bureaus of Lilly and Otsuka, and has received grants from Avanir,Biogen,BioVie,Cassava,Cerevel Therapeutics,Cognition Therapeutics,Cognitive Research, Corporation, Cognito, EIP, Genetech, Insightec, Janssen, Lilly, Otsuka, Percision Medicine, Premier Research Group, Roche, UCB Biopharma, uniQure, and Vivoryon Therapeutics.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement